Covered recipient · General Payments record
FRANCISCO A NAVEIRA
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2018–2024
$1,508.80
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.72 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $95.47 | 4 |
| Medtronic, Inc. | $52.53 | 2 |
| Collegium Pharmaceutical, Inc. | $51.47 | 3 |
| ABBVIE INC. | $30.22 | 2 |
| Avanos Medical | $29.52 | 1 |
| Averitas Pharma Inc. | $27.45 | 1 |
| SPR Therapeutics, Inc | $24.76 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $22.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105104854 | CMS |
| ABBVIE INC. | $14.22 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105104856 | CMS |
| Avanos Medical | $29.52 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149307733 | CMS |
| Averitas Pharma Inc. | $27.45 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133438679 | CMS |
| Boston Scientific Corporation | $22.30 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092355653 | CMS |
| Collegium Pharmaceutical, Inc. | $18.11 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135202304 | CMS |
| Collegium Pharmaceutical, Inc. | $16.66 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135225007 | CMS |
| Collegium Pharmaceutical, Inc. | $16.70 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135343502 | CMS |
| Medtronic, Inc. | $21.40 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119369615 | CMS |
| Medtronic, Inc. | $31.13 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119369617 | CMS |
| Nevro Corp. | $21.80 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130746670 | CMS |
| Nevro Corp. | $20.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130746668 | CMS |
| Nevro Corp. | $30.82 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130746666 | CMS |
| Nevro Corp. | $22.14 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130746622 | CMS |
| SPR Therapeutics, Inc | $24.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104931699 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.